Search clinical trials for: Lapaquistat acetate and rosuvastatin

Total 4466 results

Takeda

Completed

Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia

Hypercholesterolemia
Takeda

Completed

Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated Cholesterol

Dyslipidemia

United States
Takeda

Terminated

Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia

Hypercholesterolemia

Ukraine, Spain, Israel, Netherlands, Estonia, Russian Federation, Hungary, Norway, United Kingdom, Slovakia, Latvia
Takeda

Terminated

Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia

Hypercholesterolemia

United States
Takeda

Terminated

Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial Hypercholesterolemia

Hypercholesterolemia

France, United Kingdom, United States, Israel, Poland, Canada
Takeda

Completed

Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia

Hypercholesterolemia

United States, Canada
Takeda

Completed

Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.

Hypercholesterolemia

Serbia, Estonia, Russian Federation, Latvia
Takeda

Completed

Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia

Dyslipidemia

United States, Germany, Argentina, Mexico, Poland, South Africa, Chile, Netherlands, Peru, Estonia, Russian Federation, Czech Republic, Hungary, Lithuania, Latvia, Slovakia, United Kingdom
Takeda

Completed

Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With Hypercholesterolemia

Hypercholesterolemia
Takeda

Completed

Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels

Hyperlipidemias

United States, Canada
Takeda

Terminated

Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With Hypercholesterolemia

Hypercholesterolemia

United States, South Africa, Canada
Takeda

Completed

Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.

Hypercholesterolemia

Poland, United Kingdom, Germany, South Africa, Finland, Estonia, Czech Republic
Takeda

Completed

Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia

Hypercholesterolemia

United States
Takeda

Completed

Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.

Type 2 Diabetes

United States, Poland, United Kingdom, Germany, South Africa, Finland, Estonia, Slovakia, Czech Republic
Takeda

Completed

Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia

Hypercholesterolemia

United States, Canada
Takeda

Terminated

Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia

Hypercholesterolemia

United States
NVP Healthcare

Completed

to Investigate the Pharmacokinetic Interactions and Safety Between Rosuvastatin and Ezetimibe in Healthy Male Volunteers (NVP-1205)

Healthy
University Medicine Greifswald

Completed

Neurophysiology of Prophylactic Treatment in Migraine

Migraine

Germany
Joachim Zdolsek

Recruiting

Fluid Challenge and Plasma Volume, During Surgery (FC-VE)

Gynecologic Cancer | Colorectal Cancer | Colorectal Disorders | Urologic Cancer | Benign Neoplasm

Sweden
AstraZeneca

Completed

30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease

Dyslipidemia | Kidney Disease

United States, Puerto Rico
Ottawa Hospital Research Institute

Unknown

StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study (SAVER)

Venous Thromboembolism

Canada, Norway
Kobe University

Completed

Effect of Rosuvastatin and Eicosapentaenoic Acid on Neoatherosclerosis: The LINK-IT Trial

Coronary Artery Disease Progression
Gachon University Gil Medical Center
Daewoong Pharmaceutical Co. LTD.

Unknown

Effects of Combined Therapy With Statin Plus Fenofibrate on Coronary Atherosclerotic Plaque Compared With Statin Alone

Coronary Artery Disease

Korea, Republic of
Damanhour University
Tanta University

Completed

Type 2 Diabetic Patients Maintained on Statin Therapy

Dyslipidemia Associated With Type II Diabetes Mellitus

Egypt
Alvogen Korea

Completed

Efficacy/Safety of DP-R207 Tablet Versus CRESTOR Tablet in Patients With Primary Hypercholesterolemia (ROSE)

Primary Hypercholesterolemia

Korea, Republic of
Yuhan Corporation

Completed

Pharmacokinetic Drug Interaction Between Rosuvastatin and Valsartan

Hypertension | Hyperlipidemia

Korea, Republic of
National Institute of Diabetes and Digestive and...
National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Cancer... and other collaborators

Recruiting

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (LCN RESCU)

Cirrhosis | Cirrhosis, Liver | Cirrhosis Due to Hepatitis B | Cirrhosis Due to Hepatitis C | Cirrhosis Early | Cirrhosis Advanced | Cirrhosis Infectious | Cirrhosis Alcoholic | Cirrhosis, Biliary | Cirrhosis Cryptogenic | Cirrhosis Due to Primary Sclerosing Cholangitis

United States
Hanmi Pharmaceutical Company Limited

Unknown

Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin

Healthy

Korea, Republic of
Organon and Co

Completed

A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia (MK0653-139)

Hypercholesterolemia
Sanofi

Completed

A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin Therapy (ROZEL)

Hypercholesterolemia

China
University of Michigan
National Institutes of Health (NIH)

Completed

The Impact of Zinc Supplementation on Left Ventricular Function in Nonischemic Cardiomyopathy

Heart Failure | Cardiomyopathies

United States
AstraZeneca

Completed

A Multicenter Study Comparing the Safety and Efficacy of ABT-335 and Rosuvastatin Calcium Combination Therapy to Monotherapy in Subjects With Dyslipidemia

Dyslipidemia | Hypercholesterolemia

United States
Boryung Pharmaceutical Co., Ltd

Completed

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects

Hypertension
Capital Medical University

Unknown

A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques

Arteriosclerosis | Diabetes Mellitus | Lipid Disorder

China
BC World Pharm Co. Ltd.

Completed

Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and Metformin

Healthy

Korea, Republic of
IlDong Pharmaceutical Co Ltd

Unknown

Efficacy and Safety of Telmisartan/Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia

Hypertension | Hyperlipidemia

Korea, Republic of
LG Life Sciences

Completed

Study for Investigate the Pharmacokinetic Drug Interactions Between Gemigliptin and Rosuvastatin

Healthy

Korea, Republic of
Seoul National University Hospital

Completed

A Clinical Study to Evaluate PK, PD, and PG of Rosuvastatin in the Elderly

Elderly
Korea University Anam Hospital

Completed

Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease

Atheroscleroses, Coronary

Korea, Republic of
Boryung Pharmaceutical Co., Ltd

Completed

A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia

Essential Hypertension, Dyslipidemia

Korea, Republic of
Yonsei University

Unknown

RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)

Cardiovascular Diseases | Cerebrovascular Disease | Peripheral Atherosclerotic Disease

Korea, Republic of
Shanghai Zhongshan Hospital

Unknown

Exploring Efficacy of Intensive Rosuvastatin Treatment Peri-PCI in Chinese Patients With Non ST-segment Elevated Acute Coronary Syndrome(NSTE-ACS)

Non-ST-elevation Acute Coronary Syndromes

China
University of Campania "Luigi Vanvitelli"

Unknown

Treatment of Hyperlipidemia and Sexual Dysfunction

Sexual Dysfunction | Hyperlipidemia

Italy
Dong-A ST Co., Ltd.

Completed

Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia

Hyperlipidemia

Korea, Republic of
Daniel Vaena

Completed

PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy

Prostate Cancer | Castrate Resistant Prostate Cancer

United States
Boryung Pharmaceutical Co., Ltd
Kyungpook National University Hospital

Completed

to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin

Hypertension

Korea, Republic of
D16 Pharma & Biotec Ltd.
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh; Dhaka Medical... and other collaborators

Unknown

Efficacy and Safety Study of 5 mg and 10 mg Rosuvastatin (Cor16)

Dyslipidemia

Bangladesh
AstraZeneca

Completed

Type III Dysbetalipoproteinemia

Hyperlipoproteinemia Type III

South Africa, Norway
Odense University Hospital

Completed

Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function

Atherosclerosis | Endothelial Dysfunction

Denmark
Centre Hospitalier Universitaire Dijon
AstraZeneca

Completed

Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients

Diabetes

France

3

Subscribe